Showing results (1241-1250 of 5,058) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|October 12, 2020
Mental health status of relapsing-remitting multiple sclerosis Italian patients returning to work soon after the easing of lockdown during COVID-19 pandemic: A monocentric experienceAurora Zanghì, Emanuele D'Amico, Maria Luca, et al.
Multiple Sclerosis and Related Disorders|October 15, 2020
Frequency and etiology of acute transverse myelitis in Southern FinlandEmma Smith, Nina Jaakonmäki, Marjo Nylund, et al.
Multiple Sclerosis and Related Disorders|January 31, 2020
Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based studyLina Al-Sakran, Ruth Ann Marrie, David Blackburn, et al.
Multiple Sclerosis and Related Disorders|March 2, 2020
The effect of aquatic physical therapy on patients with multiple sclerosis: A systematic review and meta-analysisAlessio Amedoro, Anna Berardi, Antonella Conte, et al.
Multiple Sclerosis and Related Disorders|March 4, 2020
Necrotizing fungal osteomyelitis and fingolimod, 4 years after treatment with fingolimodMohammad Hossein Harirchian, Maryam Poursadeghfard, Alireza Sadeghipour, et al.
Multiple Sclerosis and Related Disorders|September 12, 2020
Experimental mouse model of NMOSD produced by facilitated brain delivery of NMO-IgG by microbubble-enhanced low-frequency ultrasound in experimental allergic encephalomyelitis miceJiaying Luo, Chong Xie, Wei Zhang, et al.
Multiple Sclerosis and Related Disorders|March 31, 2020
Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: A systematic review and meta-analysisChun-Hong Shen, Yang Zheng, Meng-Ting Cai, et al.
Multiple Sclerosis and Related Disorders|December 28, 2020
Physiotherapy use and access-barriers in persons with multiple sclerosis: A cross-sectional analysisRemo Fortunato, Nico Arie van der Maas, Ursula Biland-Thommen, et al.
Multiple Sclerosis and Related Disorders|December 28, 2020
Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectivenessBarbara Barun, Tereza Gabelić, Ivan Adamec, et al.
Multiple Sclerosis and Related Disorders|December 29, 2020
Tumefactive multiple sclerosis (TMS): A case series of this challenging variant of MSJoseph V Villarreal, Maria J Abraham, Joanne Allieza G Acevedo, et al.
Pageof 506